Ottawa is a Health Tech hub

Ottawa’s Health Tech Ecosystem


140 companies employing over 6,000 people


Home to 15 multi-national health technology companies


Over 6,500 researchers and clinicians attracting $380M in research funding annually


Third most research-intensive medical school in Canada


Fourth largest clinical trials centre in Canada


>$2B contribution to region’s GDP


Building the Health Innovation Hub in Ottawa only strengthens the ecosystem, merging the city’s dynamic high-tech and smart health innovation sectors.

The Ottawa Advantage

 

Ottawa’s strengths are best exemplified by its status as a G7 capital and its impressive tech talent base. The city is home to key federal regulatory, funding and policy agencies while boasting the highest concentration of tech talent in North America at 11.3%* which eclipses traditional global tech leaders such as the San Francisco Bay area, Toronto, Boston and Montreal.  

There are over 14,000 students enrolled in health and life sciences programs in Ottawa’s two universities (uOttawa and Carleton) and our two community colleges (Algonquin and La Cité).

Each year uOttawa graduates more than 1,200 undergraduate (Bachelors and 1st Professional Degree), 250 (from 1320 enrolled) Master’s and 65 (from 267 enrolled) Doctorate’s degrees and trains more than 120 post-doctoral fellows in life sciences and health related fields.  

Ottawa ranks first in Canada and sixth in the world for best work-life balance, thanks to high scores for city livability, including outdoor spaces, air quality and wellness and fitness**.

A research intensive landscape 

Ottawa is already firmly established as a centre for R&D, innovation and commercialization in smart health and precision medicine.

Even in the face of the COVID-19 pandemic, Ottawa’s health and medtech sector remains resilient, adding new jobs and securing research funding as demand for new products and innovations increases in this space.

Ottawa’s health and life sciences nexis provides enormous synergies and opportunities for innovation:

  • a biotherapeutics discovery engine (neurosciences, cancer, cardiovascular, rare diseases, cell and immunotherapies therapies, vaccines, regenerative medicines, etc.) coupled with,

  • smart health development engine (digital health platforms, AI, medtech and precision medicine)

  • united with our dynamic high-tech sector including over 1750 knowledge-based businesses.

* CBRE 2020 Scoring Tech Talent Report: https://www.cbre.com/research-and-reports/Scoring-Tech-8 Talent-in-North-America-2020
** Work-Life Balance: Best Cities Worldwide in 2021 | Kisi (getkisi.com)


“We’ve got discoveries to make, jobs to create, a recovery to fuel and the Ottawa Health Innovation Hub is bringing together the hearts and minds to make it all a reality.”

Sylvain Charbonneau, Ph.D., Vice-President Research, University of Ottawa

 

Videos


Time for Canada to Win at Biotechnology, especially Vaccines

 

Nov 16, 2021: Bench, Biz and Beyond Seminar Series - Investment Panel

Biotherapeutics & COVID-19 Vaccine Manufacturing at the Ottawa Hospital

 

Virica's Process Innovation Facility Virtual Tour

News


Dec 16, 2021 : "Versatile" made-in-Ottawa COVID-19 vaccine ready for human trials

Dec 16, 2021: New research, cutting-edge technology may help seniors age in place with their loved ones

Dec 15, 2021: Strategies to combat Covid-19 confused by rapidly changing research, say leading scientists

Dec 9, 2021: VBI Vaccines files new drug submission for 3-antigen hepatitis B vaccine in Canada

Nov 15, 2021: adMare BioInnovations and uOttawa Work Together to Translate University Research into Strong New Canadian Life Science Companies

Oct 20, 2021: Replica Analytics: Ottawa-based start-up is rising star in health data artificial intelligence

Oct 12, 2021: From bench to bedside: The Royal's future vision for the Brain Imaging Centre (BIC)

Oct 4, 2021: Virica Biotech Raises Series A Financing & Expands Operations to Support Clients’ Manufacturing of Viral Medicines

Sep 13, 2021: The Ottawa Hospital, the University of Alberta and BioCanRx collaborate to manufacture vaccines, gene therapies, cell therapies

Jul 21, 2021: Turnstone Biologics Raises $80 Million Series D Financing

Jun 29, 2021: Turnstone Biologics Appoints Stewart Abbot, Ph.D., as Chief Scientific Officer

Jun 21, 2021: Siemens Healthineers Announces 24,000 sq. ft. Expansion of its Ottawa Manufacturing Facility

Jun 18, 2021: Ottawa-based life sciences startup lands US$11.5M in fresh equity to fund cutting-edge cancer drugs

Jun 10, 2021: Ottawa's CANImmunize forecasts global demand for vaccination-tracking platform

Jun 8, 2021: Best Buy Health, AGE-WELL, Bruyère Research Institute and Carleton University Partner on Aging in Place Research

May 26, 2021: uOttawa, Wesley Clover launch Alacrity Ottawa to build next generation of Canadian tech entrepreneurs and companies

Mar 23, 2021: Carleton University and the Bruyère Research Institute Announce Strategic New Partnership with Health Tech Focus | Carleton Newsroom

Mar 5, 2021: Tech firms to watch: Neurovine set to expand reach of AI-powered concussion treatment

Mar 3, 2021:  Canada Foundation for Innovation awards uOttawa, Heart Institute $5.8M through 2020 Innovation Fund to study brain-heart connections with goal of transforming patient care

Feb 25, 2021: Solving Canadian health challenges through systems biology | Ottawa Institute of Systems Biology - NRC Collaboration

Jan 20, 2021: Kanata-made saliva collection kits will boost COVID-testing efforts, DNA Genotek says